[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-353810-en":59,"doc-seo-353810-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},353810,1099514068365,"Aurelia","https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Writers and readers of sialylation in immunoregulation in cancer - review","Sialic acids shape cell–cell interactions and are central to immune recognition and tissue homeostasis. In cancer, aberrant sialylation remodels the tumor microenvironment by promoting inhibitory Siglec ligands, suppressing immune effector functions, and enabling metastatic spread. This review synthesizes the coordinated roles of sialyltransferases as “writers” and Siglecs/Selectins as “readers,” detailing their dysregulation, functional diversity, and consequences for tumor–immune dynamics. It also surveys emerging therapeutic strategies targeting the sialylation axis.","REVIEWS  \nWriters and readers of sialylation in immunoregulation in cancer  \nReceived for publication, October 4, 2025, and in revised form, December 16, 2025 Published, Papers in Press, February 4, 2026 [https://doi.org/10.1016/j.jbc.2026.1](https://doi.org/10.1016/j.jbc.2026.1)11249  \nMathieu Decloquement 1 and Matthew S. Macauley 1,2,3,*  \nFrom the 1Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada; 2Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada; and 3Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada  \nReviewed by members of the JBC Editorial Board. Edited by Robert Haltiwanger  \nSialic acids are the terminal monosaccharides of the glycocalyx that critically shape cell–cell interactions and are strongly implicated in regulating immune recognition and tissue homeostasis. In cancer, aberrant sialylation rewires the tumor microenvironment by enhancing ligands of the inhibitory Siglecs, suppressing immune effector functions, and facilitating metastatic dissemination. This review provides a comprehensive synthesis of the dual role of sialyltransferases (the “writers”) and Siglecs/Selectins (the “readers”) in cancer progression. We examine the structural and functional diversity of these molecules, their dysregulation in malignancy, and their impact on tumor–immune dynamics. Finally, we highlight emerging therapeutic strategies, including sialyltransferase inhibitors, sialidase conjugates, and Siglec-targeted immunotherapies, which collectively position the sialome as a tractable frontier in cancer treatment.  \nSialic acids (Sias) are a diverse family of nine-carbon acidic monosaccharides typically located at the terminal positions of glycan chains in glycoproteins and glycolipids, forming a crucial component of the cellular glycocalyx. Their unique chemical properties, most notably a carboxyl group with apKa of approximately 2.6 (1), confer a persistent negative charge at physiological pH, profoundly influencing electrostatic interactions and cellular communication. The “sialome,” defined as the full repertoire of sialylated glycans displayed at the cell surface, is highly heterogeneous across tissues and species (1). This molecular heterogeneity is further amplified by the structural diversity of underlying glycans (N-glycans, O-glycans, and glycolipids) and a wide range of chemical modifications, including O-acetylation, sulfation, which constitutes a complex biochemical signature essential for immune self-recognition and homeostasis (2).  \nThe sialome is dynamically regulated by the coordinated action of enzymes named sialyltransferases (STs) and neuraminidases, which act as the “writers” or “erasers,” respectively, of the sialome, while two families of lectins named Selectins and sialic acid–binding immunoglobulin-like lectins (Siglecs) are considered as “readers” of these sialylated  \n* For correspondence: Matthew S. Macauley, macauley@ualberta.ca.  \npatterns. Lectins recognitions of these sialylated ligands mediate fundamental physiological processes such as immune regulation, cellular adhesion, and signaling (2).  \nAberrant sialylation is a well-recognized hallmark of malignant transformation, first identified in the late 1960s and sialoglycoconjugates play a key role in many disease processes (3, 4). In most cancers, sialylation levels increase, and during tumor progression, cancer cells direct their metabolism towards increased synthesis of sialic acids and control sialylation of glycoproteins involved in metastatic processes (5, 6). Tumor cells frequently exhibit hypersialylation, an overabundance of sialylated glycans, resulting in profound remodeling of the glycocalyx. For example, this thickened, highly charged barrier promotes immune evasion by shielding tumor cells from natural killer (NK) cell–mediated cytotoxicity (7), complement activation, via enhanced recruitment offactor H (2), and other imm","cbCaiqT2qP4WXnre","https://ap.wps.com/l/cbCaiqT2qP4WXnre","pdf",6352149,21,"English","en",105,"# Overview\n## Writers and readers: sialyltransferases, Siglecs, and Selectins\n## The sialome and its regulation\n# Cancer progression and immune regulation\n## Aberrant sialylation as a hallmark\n## Tumor-associated antigens and metastasis\n## Siglec–sialoside axis and immune checkpoint function\n# Therapeutic strategies","[{\"question\":\"What do “writers” and “readers” refer to in this review?\",\"answer\":\"“Writers” are sialyltransferases that build sialylated glycans, while “readers” are Siglecs and Selectins that recognize those sialylated ligands.\"},{\"question\":\"How does aberrant sialylation contribute to immune evasion in cancer?\",\"answer\":\"Overabundant, highly charged sialylated glycans can shield tumor cells from NK cell–mediated cytotoxicity and influence complement activation and other effector mechanisms.\"},{\"question\":\"Which types of emerging therapies are highlighted for targeting sialylation?\",\"answer\":\"The review highlights strategies such as sialyltransferase inhibitors, sialidase conjugates, and Siglec-targeted immunotherapies.\"}]","Writers and readers of sialylation in immunoregulation in cancer - review | PDF",1790107362,53,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07ae210ea5039eb6763f2c3759719fbe.webp",983,1296,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e98ff289656b7be773a24d72f5583b25.webp",982,1294,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c750afaa636e42c7fbc4cd04c31635fc.webp",981,1293,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40a5e3baedcea18ae9a726dfc9039e5b.webp",980,1292,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"writers-and-readers-of-sialylation-in-immunoregulation-in-cancer-review","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/writers-and-readers-of-sialylation-in-immunoregulation-in-cancer-review/353810/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/writers-and-readers-of-sialylation-in-immunoregulation-in-cancer-review/353810.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":34},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"What do “writers” and “readers” refer to in this review?","Question",{"text":146,"@type":147},"“Writers” are sialyltransferases that build sialylated glycans, while “readers” are Siglecs and Selectins that recognize those sialylated ligands.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"How does aberrant sialylation contribute to immune evasion in cancer?",{"text":151,"@type":147},"Overabundant, highly charged sialylated glycans can shield tumor cells from NK cell–mediated cytotoxicity and influence complement activation and other effector mechanisms.",{"name":153,"@type":144,"acceptedAnswer":154},"Which types of emerging therapies are highlighted for targeting sialylation?",{"text":155,"@type":147},"The review highlights strategies such as sialyltransferase inhibitors, sialidase conjugates, and Siglec-targeted immunotherapies.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790818519]